Clinical Trial

Pilot Study of Reduced Venetoclax Exposure

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Pilot Study of Reduced Venetoclax Exposure
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-02; most recent amendment 2025-11-19.
Trial Details
NCT Number NCT07163793
Lead Sponsor Northwell Health
Conditions Acute Myeloid Leukemia in Remission
Enrollment 41 participants
Start Date 2024-10-07
Primary Completion 2026-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-20